BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 14608905)

  • 21. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
    Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
    Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
    Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of composite classical and nodular lymphocyte predominant Hodgkin lymphoma with progression to diffuse large B-cell non-Hodgkin lymphoma: Diagnostic difficulty in fine-needle aspiration cytology.
    Das DK; Sheikh ZA; Al-Shama'a MH; John B; Alawi AM; Junaid TA
    Diagn Cytopathol; 2017 Mar; 45(3):262-266. PubMed ID: 27888658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
    Kovrigina AM; Probatova NA
    Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profiling of transcription factors Pax-5, Oct-1, Oct-2, BOB.1, and PU.1 in Hodgkin's and non-Hodgkin's lymphomas: a comparative study using high throughput tissue microarrays.
    McCune RC; Syrbu SI; Vasef MA
    Mod Pathol; 2006 Jul; 19(7):1010-8. PubMed ID: 16648862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
    Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
    Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas.
    Tian X; Xu J; Dorfman DM
    Am J Surg Pathol; 2019 Jan; 43(1):102-109. PubMed ID: 30371509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GATA3 Immunohistochemical Staining in Hodgkin Lymphoma: Diagnostic Utility in Differentiating Classic Hodgkin Lymphoma From Nodular Lymphocyte Predominant Hodgkin Lymphoma and Other Mimicking Entities.
    Kezlarian B; Alhyari M; Venkataraman G; Karner K; Inamdar KV; Menon MP
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):180-184. PubMed ID: 28877074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas.
    Krenacs L; Himmelmann AW; Quintanilla-Martinez L; Fest T; Riva A; Wellmann A; Bagdi E; Kehrl JH; Jaffe ES; Raffeld M
    Blood; 1998 Aug; 92(4):1308-16. PubMed ID: 9694719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).
    Johnson RC; Ma L; Cherry AM; Arber DA; George TI
    Am J Clin Pathol; 2013 Sep; 140(3):355-62. PubMed ID: 23955454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.
    Savage KJ; Monti S; Kutok JL; Cattoretti G; Neuberg D; De Leval L; Kurtin P; Dal Cin P; Ladd C; Feuerhake F; Aguiar RC; Li S; Salles G; Berger F; Jing W; Pinkus GS; Habermann T; Dalla-Favera R; Harris NL; Aster JC; Golub TR; Shipp MA
    Blood; 2003 Dec; 102(12):3871-9. PubMed ID: 12933571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
    Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
    Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.
    Adams H; Liebisch P; Schmid P; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):96-101. PubMed ID: 18838917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.
    O'Malley DP; Dogan A; Fedoriw Y; Medeiros LJ; Ok CY; Salama ME
    Ann Diagn Pathol; 2019 Apr; 39():105-110. PubMed ID: 30802809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.
    McQuaid DC; Katz SG; Xu ML
    Am J Clin Pathol; 2022 Aug; 158(2):173-176. PubMed ID: 35460405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma.
    Yegappan S; Coupland R; Arber DA; Wang N; Miocinovic R; Tubbs RR; Hsi ED
    Mod Pathol; 2001 Nov; 14(11):1147-56. PubMed ID: 11706077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.
    Pileri SA; Gaidano G; Zinzani PL; Falini B; Gaulard P; Zucca E; Pieri F; Berra E; Sabattini E; Ascani S; Piccioli M; Johnson PW; Giardini R; Pescarmona E; Novero D; Piccaluga PP; Marafioti T; Alonso MA; Cavalli F
    Am J Pathol; 2003 Jan; 162(1):243-53. PubMed ID: 12507907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
    Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
    Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.